Literature DB >> 29302240

Best of the 2017 AUA Annual Meeting: Highlights From the 2017 American Urological Association Annual Meeting, May 12-16, 2017, Boston, MA.

Maria J Arcila-Ruiz1, Dean G Assimos2, Benjamin M Brucker3, Michael B Chancellor4, Sasha C Druskin5, J Curtis Nickel6, Alan W Partin5, Ellen Shapiro7.   

Abstract

Keywords:  Biomarkers; Bladder exstrophy; Disorders of sexual development; Glans groove; Interstitial cystitis/bladder pain syndrome; Kallikrein; Medical expulsive therapy; Meshectomy; Microbiome; OnabotulinumtoxinA; Percutaneous nephrolithotomy; Prostate-specific antigen; Pudendal neuromodulation; Refractory overactive bladder; Reverse transcription loop-mediated isothermal amplification; Stem cell therapy; Stress urinary incontinence; Zika virus

Year:  2017        PMID： 29302240      PMCID： PMC5737344          DOI： 10.3909/riu0763

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  15 in total

1.  Early detection of prostate cancer: AUA Guideline.

Authors:  H Ballentine Carter; Peter C Albertsen; Michael J Barry; Ruth Etzioni; Stephen J Freedland; Kirsten Lynn Greene; Lars Holmberg; Philip Kantoff; Badrinath R Konety; Mohammad Hassan Murad; David F Penson; Anthony L Zietman
Journal:  J Urol       Date:  2013-05-06       Impact factor: 7.450

Review 2.  Blood-based and urinary prostate cancer biomarkers: a review and comparison of novel biomarkers for detection and treatment decisions.

Authors:  R J Hendriks; I M van Oort; J A Schalken
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-12-06       Impact factor: 5.554

3.  Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging.

Authors:  W J Catalona; P C Southwick; K M Slawin; A W Partin; M K Brawer; R C Flanigan; A Patel; J P Richie; P C Walsh; P T Scardino; P H Lange; G H Gasior; K G Loveland; K R Bray
Journal:  Urology       Date:  2000-08-01       Impact factor: 2.649

4.  Prostate Health Index density improves detection of clinically significant prostate cancer.

Authors:  Jeffrey J Tosoian; Sasha C Druskin; Darian Andreas; Patrick Mullane; Meera Chappidi; Sarah Joo; Kamyar Ghabili; Mufaddal Mamawala; Joseph Agostino; Herbert B Carter; Alan W Partin; Lori J Sokoll; Ashley E Ross
Journal:  BJU Int       Date:  2017-02-06       Impact factor: 5.588

5.  Prostate-specific antigen/solvent interaction analysis: a preliminary evaluation of a new assay concept for detecting prostate cancer using urinary samples.

Authors:  Mark Stovsky; Lee Ponsky; Srinivas Vourganti; Peter Stuhldreher; Mike B Siroky; Victor Kipnis; Olga Fedotoff; Larissa Mikheeva; Boris Zaslavsky; Arnon Chait; J Stephen Jones
Journal:  Urology       Date:  2011-07-23       Impact factor: 2.649

6.  The Single-parameter, Structure-based IsoPSA Assay Demonstrates Improved Diagnostic Accuracy for Detection of Any Prostate Cancer and High-grade Prostate Cancer Compared to a Concentration-based Assay of Total Prostate-specific Antigen: A Preliminary Report.

Authors:  Eric A Klein; Arnon Chait; Jason M Hafron; Kenneth M Kernen; Kannan Manickam; Andrew J Stephenson; Mathew Wagner; Hui Zhu; Aimee Kestranek; Boris Zaslavsky; Mark Stovsky
Journal:  Eur Urol       Date:  2017-04-07       Impact factor: 20.096

7.  Vaginal Mesh Removal Outcomes: Eight Years of Experience at an Academic Hospital.

Authors:  Olivia O Cardenas-Trowers; Pouran Malekzadeh; David E Nix; Kenneth D Hatch
Journal:  Female Pelvic Med Reconstr Surg       Date:  2017 Nov/Dec       Impact factor: 2.091

Review 8.  Genomic Predictors of Outcome in Prostate Cancer.

Authors:  Peter J Boström; Anders S Bjartell; James W F Catto; Scott E Eggener; Hans Lilja; Stacy Loeb; Jack Schalken; Thorsten Schlomm; Matthew R Cooperberg
Journal:  Eur Urol       Date:  2015-04-23       Impact factor: 20.096

9.  Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.

Authors:  Ian M Thompson; Donna K Pauler; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Howard L Parnes; Lori M Minasian; Leslie G Ford; Scott M Lippman; E David Crawford; John J Crowley; Charles A Coltman
Journal:  N Engl J Med       Date:  2004-05-27       Impact factor: 91.245

10.  A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden.

Authors:  Andrew J Vickers; Angel M Cronin; Gunnar Aus; Carl-Gustav Pihl; Charlotte Becker; Kim Pettersson; Peter T Scardino; Jonas Hugosson; Hans Lilja
Journal:  BMC Med       Date:  2008-07-08       Impact factor: 8.775
View more
  1 in total

1.  Qianlie Xiaozheng Decoction Induces Autophagy in Human Prostate Cancer Cells via Inhibition of the Akt/mTOR Pathway.

Authors:  Yuehua Xu; Xueting Cai; Bin Zong; Rui Feng; Yali Ji; Gang Chen; Zhongxing Li
Journal:  Front Pharmacol       Date:  2018-04-04       Impact factor: 5.810
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.